Area of research
Genetics · Cancer Research
Research interest
Research interests include Estrogen and related hormone effects, NF-κB Signaling Pathways, Cell Adhesion Molecules Research, and Melanoma and MAPK Pathways.
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity
Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development
Extending the Calpain–Cathepsin Hypothesis to the Neurovasculature: Protection of Brain Endothelial Cells and Mice from Neurotrauma
Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib
Coactivation of Estrogen Receptor and IKKβ Induces a Dormant Metastatic Phenotype in ER-Positive Breast Cancer
Identification of HDAC6‐Selective Inhibitors of Low Cancer Cell Cytotoxicity
GRP78 is a novel receptor initiating a vascular barrier protective response to oxidized phospholipids
Gβ phosphorylation is critical for efficient chemotropism in yeast
Measurement of local permeability at subcellular level in cell models of agonist- and ventilator-induced lung injury